Top Markets
Coin of the day
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
Classement en actions #21570
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing. This therapy is currently undergoing Phase I/II clinical evaluations, both as a standalone treatment and in combination with other drugs, targeting a broad range of solid tumors and hematologic malignancies. Furthermore, the company is advancing CYT-1853, another promising candidate in preclinical development for similar oncological indications. Cyteir Therapeutics was established in 2012 and is headquartered in Lexington, Massachusetts.
Prix de l'action
$3.01
Dernière synchronisation: 2024-04-12
Capitalisation boursière
$104.64M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Cyteir Therapeutics, Inc. (CYT)

Catégorie

Historique du prix de l'action pour Cyteir Therapeutics, Inc. (CYT)
Prix de clôture le plus élevé : $3.01 le 2024-04-01

Prix de clôture le plus bas : $18.73 le 2021-06-01
Historique du prix de l'action de Cyteir Therapeutics, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 -2.00%
2023 125.69%
2022 -88.47%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH